| __timestamp | ADMA Biologics, Inc. | MorphoSys AG |
|---|---|---|
| Wednesday, January 1, 2014 | 9517014 | 55962693 |
| Thursday, January 1, 2015 | 7015946 | 78655788 |
| Friday, January 1, 2016 | 7688238 | 95723069 |
| Sunday, January 1, 2017 | 6229587 | 116808575 |
| Monday, January 1, 2018 | 3926120 | 106397017 |
| Tuesday, January 1, 2019 | 2343848 | 108431600 |
| Wednesday, January 1, 2020 | 5907013 | 141426832 |
| Friday, January 1, 2021 | 3646060 | 225200000 |
| Saturday, January 1, 2022 | 3613764 | 297812160 |
| Sunday, January 1, 2023 | 3300000 | 283614139 |
Infusing magic into the data realm
In the competitive landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, MorphoSys AG has consistently outpaced ADMA Biologics, Inc. in R&D investment. From 2014 to 2023, MorphoSys AG's R&D expenses surged by over 400%, peaking in 2022 with a staggering 298 million dollars. In contrast, ADMA Biologics, Inc. saw a decline of approximately 65% in their R&D spending during the same period, with a notable drop from 9.5 million dollars in 2014 to just 3.3 million dollars in 2023.
This strategic divergence highlights MorphoSys AG's aggressive pursuit of innovation, while ADMA Biologics, Inc. appears to be adopting a more conservative approach. As the biotech industry continues to evolve, these spending patterns may significantly influence each company's future growth and market positioning.
Comparing Innovation Spending: Merck & Co., Inc. and ADMA Biologics, Inc.
GSK plc or MorphoSys AG: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and MorphoSys AG
Research and Development Investment: Neurocrine Biosciences, Inc. vs MorphoSys AG
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ADMA Biologics, Inc.
R&D Insights: How Bio-Techne Corporation and ADMA Biologics, Inc. Allocate Funds
Research and Development Expenses Breakdown: Ionis Pharmaceuticals, Inc. vs ADMA Biologics, Inc.
R&D Spending Showdown: Ionis Pharmaceuticals, Inc. vs MorphoSys AG
Research and Development: Comparing Key Metrics for TG Therapeutics, Inc. and ADMA Biologics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for ADMA Biologics, Inc. and Iovance Biotherapeutics, Inc.
Research and Development: Comparing Key Metrics for ADMA Biologics, Inc. and Viridian Therapeutics, Inc.
R&D Spending Showdown: Ultragenyx Pharmaceutical Inc. vs MorphoSys AG